Acadia Pharmaceuticals Gets Health Canada Approval for DAYBUE™ in Rett Syndrome
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced that Health Canada has granted marketing authorization for DAYBUE™ (trofinetide) to treat Rett syndrome in patients aged two and older. This approval, under…
bit.bio Secures Landmark Patent Defense for opti-ox™ Cell Programming Technology
bit.bio, a leader in synthetic biology focused on coding human cells for innovative therapies, has successfully defended its foundational European patent for opti-ox. This groundbreaking technology allows for the deterministic…
Celltrion Reveals Two-Year Post-Hoc Analysis Results for Subcutaneous Infliximab (CT-P13 SC) in IBD Treatment
Celltrion has announced the two-year results of dose escalation therapy with subcutaneous infliximab (CT-P13 SC) at the United European Gastroenterology (UEG) Week 2024 in Vienna. A post-hoc analysis of the…
FDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) has announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for use alongside PD-1/PD-L1 inhibitors or docetaxel. This treatment is intended for adult…
Simple Blood Test Can Predict Future Heart Attacks and Cardiac Events
Siemens Healthineers has announced a new prognostic claim for its Atellica IM High-Sensitivity Troponin I (TnIH) test, significantly enhancing care for at-risk cardiac patients in the U.S. This straightforward blood…
Airway Therapeutics Launches Phase 3 Study of Zelpultide Alfa for Preterm Infants at Risk of BPD
Airway Therapeutics, Inc. has announced the launch of a multinational Phase 3 clinical trial for zelpultide alfa (rhSP-D). This study aims to prevent bronchopulmonary dysplasia (BPD) and mitigate lung injury…
Invisalign® Palatal Expander Now Available in Hong Kong for Dental Growth
Align Technology, Inc. (Nasdaq: ALGN), a global leader in medical devices known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, has announced the launch of its…
MEDiC Life Sciences Secures $5M Investment from LG and Hanmi for Cancer Biomarker Technology
MEDiC Life Sciences, a prominent functional genomics startup in Silicon Valley, has announced a $5M strategic investment from LG and Hanmi Pharmaceutical. This funding precedes MEDiC’s upcoming Series-A round later…
FDA Clears SPECTRALIS Flex Module for Enhanced Ophthalmic Imaging Access
Heidelberg Engineering, a leader in ophthalmic imaging and healthcare data solutions, has announced FDA clearance for the SPECTRALIS® Flex Module. This innovative multimodal platform is specifically designed for diagnostic imaging…
MEDiC Life Sciences Partners with Hanmi Pharmaceutical on Cancer Biomarker Discovery
MEDiC Life Sciences, a Silicon Valley biotech startup, has announced a research collaboration with Hanmi Pharmaceutical, a prominent biopharma company based in Korea. Through this partnership, MEDiC will utilize its…
Exelixis and Merck Collaborate on Zanzalintinib Trials for Cancer
Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, have announced a clinical development collaboration. The partnership will evaluate the investigational tyrosine kinase…
Bausch + Lomb Gets FDA Approval for enVista® Envy™ Intraocular Lens
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL),…